FDA
approval
· 2022-10-11
FDA Approved: BORTEZOMIB — Original Application (Somerset Therapeutics LLC)
Summary
FDA approved a generic version of Bortezomib under an Original Application (ANDA 211898) for Somerset Therapeutics LLC. The product is used for the treatment of…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for BORTEZOMIB (BORTEZOMIB)